BRENDI GALE: Open Payments
NPI 1184292880 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 55 payments from 12 companies in 2025. Trend: 2023 $622 · 2024 $1,024 · 2025 $1,022
Food & beverage: $953Education: $69
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $192 |
| Novartis Pharmaceuticals Corporation | 10 | $180 |
| ABBVIE INC. | 12 | $148 |
| Lilly USA, LLC | 6 | $135 |
| Janssen Biotech, Inc. | 3 | $108 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $70 |
| GENZYME CORPORATION | 2 | $62 |
| Galderma Laboratories, L.P. | 2 | $35 |
| PFIZER INC. | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
Products named: Bimzelx, COSENTYX, SKYRIZI, TREMFYA, TALTZ, EBGLYSS, DUPIXENT, ILUMYA.
Industry payments across AR — which companies pay providers there.
